Industry News
Registrations open for AusBiotech 2013
The biggest Australian biotechnology event for the year, the AusBiotech 2013 national conference, will be held from 29 October-1 November in Brisbane. Registrations are now open. [ + ]
ResMed launches home COPD treatment
ResMed (ASX:RMD) has launched the first FDA-approved home VPAP COPD treatment device into the US market. [ + ]
Phylogica granted EU Phylomer patent
Phylogica (ASX:PYC) has received a European patent covering the use of Phylomer peptides from its libraries to treat ischemic conditions including stroke and ARDS. [ + ]
International DNA Day
As well as being Anzac Day, 25 April is International DNA Day. [ + ]
Patrys cleared to escalate dose in myeloma trial
The safety board monitoring Patrys’s (ASX:PAB) phase I/IIa trial of PAT-SM6 in multiple myeloma has cleared the company to move up to a higher dose. [ + ]
Prima names new advisors for CVac programs
Prima BioMed (ASX:PRR) has appointed oncology experts Dr Holbrook Kohrt and Dr Pamela Klein as clinical advisors for its cancer vaccine programs. [ + ]
Chief Scientist urges more thought for the future
The importance of science to Australia’s future and its place in the world will be the subject of a free public lecture in Perth next month by Australia’s Chief Scientist, Professor Ian Chubb. [ + ]
Leading scientific experts appointed to Carbon Farming Committee
The Parliamentary Secretary for Climate Change, Industry and Innovation, Yvette D’Ath, today appointed Dr Tony Press, CEO of the Australian Antarctic Climate and Ecosystems Cooperative Research Centre, as Chair of the Domestic Offsets Integrity Committee. D’Ath also appointed Noel Peters as a new member of the committee. [ + ]
Discovery of three new molecules opens door for breast, prostate cancer treatments
A team of Western Australian cancer researchers interested in the strong link between hormones and cancer have discovered three new molecules that may have an important role to play in future breast and prostate cancer treatments. [ + ]
Alchemia lands discovery deal with AstraZeneca
Alchemia (ASX:ACL) has entered a small molecule drug discovery collaboration with AstraZeneca based on the former’s VAST chemistry platform. [ + ]
Bionomics initiates manufacturing of tumour drug
Bionomics (ASX:BNO) has contracted Lonza to produce tumour drug candidate BNC101 ahead of clinical trials anticipated for 2014. [ + ]
New immune cell in skin
A new type of immune cell in skin that is involved in warding off parasites could be linked to eczema and allergic skin diseases. [ + ]
Registration deadline looming for R&D Tax Incentive
The registration of research and development (R&D) activities, under the R&D Tax Incentive, closes next week for the 2011-12 year. [ + ]
Reigniting cell death
Australian researchers have taken an important step towards designing a potential new anticancer agent. [ + ]
Developing a faster diagnosis of bacterial meningitis
Using joint funding from the Paige Weatherspoon Foundation and the Macquarie University Office of Commercialisation, a team of researchers have recently made headway in developing a faster diagnosis for bacterial meningitis. [ + ]
